As threats to the pharmaceutical supply chain prevail, the industry is seeing increased regulatory scrutiny as well as more inspection requirements, says industry panel.
Almost half of all manufacturers have reported production downtime resulting from barcode labelling problems, according to a new survey.
Drugmakers need more certainty and reliabilty around their supply chain in light of increased regulatory vigilance says Mylan, itself carrying out remediation across several Indian facilities.
Minerals used to manufacture two of Charles River Laboratories’ products may be derived from questionable sources in Africa, though following a review of suppliers, the company has yet to fully understand where exactly they’re coming from, according to...
The CMO (contract manufacturing organization) industry is ripe for consolidation as the rise in outsourcing continues and clients look to simplify their supply chains, DPx CEO James Mullen told Outsourcing-Pharma.com on Wednesday.
How can a pharma company invest in continuous manufacturing without bleeding money when it retreats from a local market? Pfizer’s answer is production pods it can roll out anywhere in the world via helicopter… and pack away again if a market turns.
Consolidation in the healthcare logistics industry is inevitable, says PCI as it opens a US storage and distribution facility for clinical trial materials.
Pre CPhI Special
The world is getting larger, at least it is in terms of the pharmaceutical industry, according to execs who cite security concerns when shipping to new markets as the top logistics worry.
The high cost and complexity of producing biopharmaceuticals for clinical trials limits supplies and makes effective logistics even more important than for small molecule studies says Almac.
Temperature fluctuations during shipping have led to costly clinical data delays and product recalls, but such problems can be avoided through supply chain pre-planning say distribution firms.
DHL has acquired or partnered with four GMP clinical trials supply depots in the Philippines, Egypt, Belarus and Turkey.
In light of the implementation of the Drug Quality and Security Act of 2013 in the US, which calls for the phased implementation of electronic tracking down to the package level, companies are looking at options to catch up and reduce counterfeiting at...
Parexel has enlarged its clinical trial supply network with the opening of a distribution centre in Singapore and expansion of its Massachusetts facilities.
The UK Government has set out to make Britain a more attractive place from which to source drugs and ingredients by awarding a series of taxpayer funded grants to supply chain focused innovation projects.
The US FDA announced on Monday that it would initiate a Secure Supply Chain Pilot Program to enhance the security of imported drugs.
Packaging Coordinators Inc (PCI) has begun construction on a US clinical storage and global distribution facility with demand from international clients being a key driver.
The two-year pilot project will help the US Food and Drug Administration further assess the growing number of companies and countries involved in importing drugs to the US.
The ever-expanding market in China has plenty of room for 3rd party pharmaceutical distribution and logistics companies says UPS as it opens a new facility in Zhejiang Province.
The US House Energy & Commerce Committee on Wednesday advanced a bill to further secure the US prescription drug supply chain, though it stops short of mandating unit-level, electronic tracking and tracing of drugs.
Globalisation, outsourcing and a move towards biopharmaceuticals are leading innovation for pharma distribution companies, according to DHL Global Forwarding.
Axon has chosen Swiss CMO Bachem to manufacture the peptide API and finished form for its clinical trials.
Marken says the opening of its new pharma depot is part of a whole strategy within China and was driven by demand from an increase in clinical trials.
Worries about increasing regulatory scrutiny and penalties top the list of API and drugmaker concerns about supply chains according to a survey by contract distributor UPS.
Biopharma manufacturers are putting their supply chains at risk by failing to prepare for emergencies, according to a new study by Best Practices, LLC.
Outsourcing-Pharma.com presents a very special round-up of the latest movers and shakers in the industry, including news from our own Nick Taylor, as well as updates from Marken, Clarus Therapeutics and Penn Pharma.
in-PharmaTechnologist.com presents the latest new facilities to spring up all over the world, including a plasma-based therapy expansion for Baxter, a North African foray for Julphar, and a supply chain step-up for Vetter.
Marken is looking at setting up a home delivery service as a further expansion of its clinical trial and logistics offering.
Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant.
Sigma Aldrich says new packaging facility in China will shorten supply chains and help it build in an increasingly important regional market.
Marken will open new offices in India in the latest step in its bid to become a full service supply chain services contractor.
Logistics contractor Marken plans to ramp up its activities in China with a new Beijing depot set to open later this year.
DHL gains license for packing & labelling medical devices
DHL has obtained a license for packaging, labelling and storing medical devices at its logistics site in Tokyo, Japan.
PIC/S has strengthened promotion of global GDP harmonisation and confidentiality in a revision to its documentation.
Amarin wants fourth omega-3 API supplier for AM101
Amarin plans to add a fourth API maker to its supply chain as it prepares for a potential launch of its triglyceride lowering therapy, AMR101, in the US in 2012.
Greater collaboration between regulators, suppliers and manufacturers is needed to reverse decades of supply chain neglect, an expert said.
The USP has published draft supply chain integrity guidance outlining steps to stop counterfeit or adulterated drugs reaching patients.
Supply chain delays driving up Indian logistics costs
State-border delays, tolls and paperwork are increasing logistics costs in India and making transit less efficient than the EU and China, a report found.
SAFC sets sights on a "proactive" supply chain management system
SAFC is putting special focus on supply chain and quality management as part of its new strategic plan.
FDA must be empowered to oversee supply chain; report
Congress must grant the FDA additional powers to bring oversight of manufacturing inline with shifts in production practices, according to a report.
Hamburg calls for more FDA powers to ensure drug quality
FDA Commissioner Hamburg has asked for more supply chain security and quality control regulatory powers.
CMO consolidation will support 100% virtual supply chains
Consolidation of CMOs will support use of completely outsourced production and distribution networks in the near future.
Radical overhaul of ill-equipped pharma supply chains needed
A radical overhaul of pharmaceutical supply chains is needed to prepare them for the type of products currently in development, says PwC.
UK issues supply chain guide to prevent drug shortages
Biopharm manufacturers should hold a volume of buffer stock to ensure it can maintain supply during fluctuations in demand, says UK guidance.
Senior exec support key to supply chain change success
Supply chain strategy implementations are more likely to succeed when they have the active support of the board and senior executives, according to research.
UPS expands global healthcare network with new facilities
United Parcel Service (UPS) will open four global healthcare distribution centres to accommodate its fast growing healthcare business and a rising global customer base.
Anti-fake readiness a factor for emerging biotech buyers
Biopharm are increasingly assessing the threat counterfeiting and diversion pose to emerging biotechs when planning an acquisition, according to a white paper.
Outsourcing a threat to supply chains, says PwC
Increased outsourcing carries a significant operational risk according to executives quizzed in a new survey by PwC and Axendia.
Oracle adds ePedigree system to secure supply chain
Oracle has introduced an integrated mass-serialisation and pedigree application to improve pharma supply chain integrity.
FDA advises on preventing and responding to drug theft
The FDA has issued a letter to stakeholders detailing best practices for preventing and responding to theft of pharma products.
Streamlining of Indian supply chain needed to cut costs
Rising use of biologics and a tax initiative will drive the streamlining of Indian supply chains, helping companies to deliver drugs at affordable prices, according to PwC.